Cargando…

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report

BACKGROUND: Serotonin syndrome has been recognized as a serious adverse reaction to antidepressants and is characterized by sudden or severe autonomic nerve dysfunction and neuromuscular symptoms. Without an accurate diagnosis and prompt treatment, serotonin syndrome progresses rapidly and can be li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianhong, Yu, Jiao, Qu, Kankan, Yin, Jiajun, Zhu, Chunming, Liu, Xiaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598681/ https://www.ncbi.nlm.nih.gov/pubmed/37886119 http://dx.doi.org/10.3389/fpsyt.2023.1257984

Ejemplares similares

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
por: Eichentopf, Luzie, et al.
Publicado: (2022)

Differential Effects of Single-Dose Escitalopram on Cognitive and Affective Interference during Stroop Task
por: Rahm, Christoffer, et al.
Publicado: (2014)

An interesting case of serotonin syndrome precipitated by escitalopram
por: Sanyal, Debasish, et al.
Publicado: (2010)

Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
por: Xu, Jiao, et al.
Publicado: (2021)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Behavioral, cortical and autonomic effects of single-dose escitalopram on the induction and regulation of fear and disgust: Comparison with single-session psychological emotion regulation with reappraisal
por: Sklivanioti Greenfield, Myrto, et al.
Publicado: (2023)

Unilateral Galactorrhea Associated with Low-dose Escitalopram
por: Ravi, P. Bangalore, et al.
Publicado: (2014)

Serotonin Surge: Intravenous Escitalopram as a Rare Cause of Drug-Induced Aplastic Anaemia
por: Hussain, Murtaza, et al.
Publicado: (2022)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
por: Krause-Sorio, Beatrix, et al.
Publicado: (2020)

Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
por: Kimura, Kenichi, et al.
Publicado: (2023)

Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress
por: Yang, Lixia, et al.
Publicado: (2018)

Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder
por: Zhou, Jingjing, et al.
Publicado: (2021)

No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness
por: Koopmans, Anne B., et al.
Publicado: (2018)

Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
por: Margoob, Mushtaq A., et al.
Publicado: (2008)

Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity
por: Guinchat, Vincent, et al.
Publicado: (2022)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
por: Huan, Yuhang, et al.
Publicado: (2021)

Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
por: Cigognini, Marco Aurélio, et al.
Publicado: (2022)

Rewiring of the Serotonin System in Major Depression
por: Vahid-Ansari, Faranak, et al.
Publicado: (2021)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
por: François, C, et al.
Publicado: (2008)

A Systematic Review and Individual Patient Data Network Analysis of the Residual Symptom Structure Following Cognitive-Behavioral Therapy and Escitalopram, Mirtazapine and Venlafaxine for Depression
por: Whiston, Aoife, et al.
Publicado: (2022)

Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022)

Optimizing clopidogrel dose response: a new clinical algorithm comprising CYP2C19 pharmacogenetics and drug interactions
por: Saab, Yolande B, et al.
Publicado: (2015)

Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018)

Serotonin Syndrome: An Emerging Reality in the Emergency Department
por: Monteiro, Marta, et al.
Publicado: (2023)

CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
por: Bernini de Brito, Rodrigo, et al.
Publicado: (2020)

Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation vs. Escitalopram for Patients With Mild-to-Moderate Depression (TECAS): Study Design for a Randomized Controlled, Non-inferiority Trial
por: Yang, Sichang, et al.
Publicado: (2022)

Aggression Traits in Youth Psychopathy: The Key Role of Serotonin
por: Vicario, Carmelo M.
Publicado: (2014)

Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan
por: Afridi, Muhammad Iqbal, et al.
Publicado: (2020)

Association between Genotype of the Serotonin Transporter-Linked Polymorphic Region of the Serotonin Transporter Gene and Age of Onset of Methamphetamine Use: a Preliminary Analysis
por: Johnson, Bankole A., et al.
Publicado: (2010)

Mydriasis caused by ESCITALOPRAM: A case report
por: Bouattour, N., et al.
Publicado: (2023)

The effect of a single dose of escitalopram on sensorimotor networks
por: Weisstanner, Christian, et al.
Publicado: (2018)

Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome
por: Noda, Mami, et al.
Publicado: (2018)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

Linezolid-Induced Near-Fatal Serotonin Syndrome During Escitalopram Therapy: Case Report and Review of Literature
por: Kulkarni, Ranganath R., et al.
Publicado: (2013)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)

Kappa Opioid Receptors Reduce Serotonin Uptake and Escitalopram Efficacy in the Mouse Substantia Nigra Pars Reticulata
por: West, Alyssa M., et al.
Publicado: (2023)

Low dose Amantadine and Escitalopram combination in Atypical Parkinsonian disorders- A Retrospective chart review
por: Tripathi, S. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f2b6v745uh6n1faoh6paedntl6